3 completed, 1 unknown. 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Placebo nasal gel: new trials by email Literature Review of Placebo nasal gel trials Research Report on Placebo nasal gel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn More About How Well Oxymetazoline HCl 0.05% Nasal Gel Works and How Safe It Is in Healthy Adults Oxymetazoline HCl 0.05% nasal gel, Placebo nasal gel - Nasal Congestion, Nasal Obstruction | Phase 2 | Completed | Bayer | 120 | 2026-04-20 | 2026-06-08 |
| Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance DPI-386 Nasal Gel, Placebo Nasal Gel - Motion Sickness, Space, Motion Sickness | Phase 2 | Unknown | Repurposed Therapeutics, Inc. | 30 | 2022-01-21 | 2024-05-17 |
| Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects Scopolamine, Placebo Nasal Gel - Motion Sickness | Phase 3 | Completed | Repurposed Therapeutics, Inc. | 98 | 2019-06-07 | 2023-05-06 |
| Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects XF-73 nasal gel, Placebo nasal gel, Chlorhexidine gluconate 2% topical cloths - Staphylococcus Aureus Infection | Phase 1 / Phase 2 | Completed | Destiny Pharma Plc | 60 | 2014-09-01 | 2016-10-07 |
Motion Sickness (2) · Nasal Obstruction (1) · Space Motion Sickness (1) · Staphylococcal Infections (1)
Repurposed Therapeutics, Inc. (2) · Bayer (1) · Destiny Pharma Plc (1)
United States (2) · Canada (1) · United Kingdom (1)
David R Helton (1) · Ian Mr Hayter, BSc (1) · Scott J Wood, PhD (1)